Nuclear receptor modulators inhibit osteosarcoma cell proliferation and tumour growth by regulating the mTOR signaling pathway

Osteosarcoma is the most common primary malignant bone tumour in children and adolescents. Chemoresistance leads to poor responses to conventional therapy in patients with osteosarcoma. The discovery of novel effective therapeutic targets and drugs is still the main focus of osteosarcoma research. N...

Descripción completa

Detalles Bibliográficos
Autores principales: Yuan, Baoshi, Shi, Kexin, Zha, Juanmin, Cai, Yujia, Gu, Yue, Huang, Kai, Yue, Wenchang, Zhai, Qiaocheng, Ding, Ning, Ren, Wenyan, He, Weiqi, Xu, Ying, Wang, Tao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9867777/
https://www.ncbi.nlm.nih.gov/pubmed/36681687
http://dx.doi.org/10.1038/s41419-022-05545-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9867777/
https://www.ncbi.nlm.nih.gov/pubmed/36681687
http://dx.doi.org/10.1038/s41419-022-05545-7

Ejemplares similares